Hematology/Oncology

Top Story

MD Anderson appoints orthopedic oncology department chair

August 29, 2015

Valerae O. Lewis, MD, has been named chair of the department of orthopedic oncology at The University of Texas MD Anderson Cancer Center.

Lewis, whose clinical focus is sarcoma, is recognized for her expertise in pelvic and limb surgery for adults and children.

Timothy J. Ley, MD In the Journals

Persistent mutations may predict EFS, OS outcomes in AML

August 28, 2015
Persistent leukemia-associated mutations in at least 5% of bone marrow cells in day 30 remission samples appeared to significantly increase the risk for relapse and…
Allison W. Kurian, MD, MSc In the Journals

Impact of recurrence score assay on chemotherapy receipt varies based on breast cancer risk

August 28, 2015
The use of a 21-gene recurrence score assay appeared associated with greater use of chemotherapy in patients with low-risk breast cancer and a reduced use of…
In the Journals

Risk protocol identifies patients with cancer not allergic to carboplatin, oxaliplatin

August 28, 2015
Patients with cancer who had a history of presumed carboplatin- and oxaliplatin-induced hypersensitivity reaction did not appear allergic to the chemotherapy drugs after…
In the Journals

Intestinal obstruction a long-term risk for survivors of childhood cancer

August 28, 2015
Survivors of childhood cancer face a long-term risk for intestinal obstruction requiring surgery as a result of their treatment, according to findings from the Childhood…
More News Headlines »
CME
Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Meeting News Coverage Video
VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated…
More »
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »